“Clinical Approach to Fibromyalgia: Synthesis of Evidence-based Recommendations, a Systematic Review”

Weiser, 2011 Queiroz, 2013, Worldwide epidemiology of fibromyalgia, Curr Pain Headache Rep, 17, 356, 10.1007/s11916-013-0356-5 Eich, 2012, Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis, Schmerz, 26, 247, 10.1007/s00482-012-1169-x Wolfe, 2010, The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity, Arthritis Care Res (Hoboken), 62, 600, 10.1002/acr.20140 Boonen, 2005, Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis, Ann Rheum Dis, 64, 396, 10.1136/ard.2003.019711 Henriksson, 2005, Women with fibromyalgia: work and rehabilitation, Disabil Rehabil, 27, 685, 10.1080/09638280400009089 Guirguis-Blake, 2007, Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development, Ann Intern Med, 147, 117, 10.7326/0003-4819-147-2-200707170-00170 2011 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Buckhardt, 2005 Forte, 2015 Ablin, 2013, Guidelines for the diagnosis and treatment of the fibromyalgia syndrome, Harefuah, 152, 742 Secretaría de Salud, 2008 Carville, 2008, EULAR evidence-based recommendations for the management of fibromyalgia syndrome, Ann Rheum Dis, 67, 536, 10.1136/ard.2007.071522 University of Texas, 2009 Ministerio de Sanidad, 2011 Agència d’Informació, 2011 Fitzcharles, 2012, 2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary, Pain Res Manag, 18, 119, 10.1155/2013/918216 De Silva, 2010, Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review, Rheumatology (Oxf), 49, 1063, 10.1093/rheumatology/keq025 Häuser, 2014, Review of pharmacological therapies in fibromyalgia syndrome, Arthritis Res Ther, 16, 201, 10.1186/ar4441 Saturno, 2013 Haynes, 2006, Of studies, syntheses, synopses, summaries, and systems: the 5 S evolution of information services for evidence-based healthcare decisions, Evid Based Nurs, 11, 162, 10.1136/ebm.11.6.162-a Institute of Medicine, 2011 Brouwers, 2010, AGREE II: advancing guideline development, reporting, and evaluation in health care, Prev Med, 51, 421, 10.1016/j.ypmed.2010.08.005 Shiffman, 2005, The guideline implementability appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation, BMC Med Inform Decis Mak, 5, 23, 10.1186/1472-6947-5-23 Stanos, 2012, Focused review of interdisciplinary pain rehabilitation programs for chronic pain management, Curr Pain Headache Rep, 16, 147, 10.1007/s11916-012-0252-4 Kumar, 2010, Physical therapy in palliative care: from symptom control to quality of life: a critical review, Indian J Palliat Care, 16, 138, 10.4103/0973-1075.73670 Nielson, 2001, Biopsychosocial approaches to the treatment of chronic pain, Clin J Pain, 17, S114, 10.1097/00002508-200112001-00020 Engel, 1977, The need for a new medical model: a challenge for biomedicine, Science, 196, 129, 10.1126/science.847460 Escudero-Carretero, 2010, Fibromyalgia patient perception on their disease and health system. Qualitative research study, Reumatol Clin, 6, 16, 10.1016/j.reuma.2009.04.008 Häuser, 2013, Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome, Cochrane Database Syst Rev, 1, CD010292 Painter, 2013, Chronic opioid use in fibromyalgia syndrome: a clinical review, J Clin Rheumatol, 19, 72, 10.1097/RHU.0b013e3182863447 King, 2014, Determinants of increased opioid-related mortality in the United States and Canada, 1990–2013: a systematic review, Am J Public Health, 104, e1, 10.2105/AJPH.2014.301966 Centers for Disease Control and Prevention, 2012, Prevention strategies. CDC grand rounds: prescription drug overdoses – a U.S. epidemic, JAMA, 307, 774